Capricor Therapeutics
CAPR
CAPR
61 hedge funds and large institutions have $30.7M invested in Capricor Therapeutics in 2024 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
+5
Holders Change %
+8.93%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
18
Reduced
16
Closed
17
Calls
$1.36M
Puts
$1.84M
Net Calls
-$480K
Net Calls Change
-$1.14M
Top Buyers
| 1 |
1
BlackRock
New York
|
$7.77M |
| 2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$3.06M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$1.91M |
| 4 |
4
Millennium Management
New York
|
$2.29M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$7.39M |
